Roka Bioscience (ROKA) Reports Q4 Loss of $3.72

Roka Bioscience (NASDAQ: ROKA) reported Q4 EPS of ($3.72), versus ($5.77) reported last year. Revenue for the quarter came in at $1.9 million, versus $1.5 thousand reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Vireo Growth completes acquisition of C21 Investments
• S&P 500 may pull back before midterms, but Citi says buy the dip